Belite Bio Inc ADR（BLTE）— 技术面状态
数据截至2026-09-21 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记，不构成投资建议。
Trades +6.4% vs the 50-day and +8.3% vs the 200-day average, 13.3% below the 52-week high and +154.2% off the 52-week low; a golden cross printed 11 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线+2.8%
- 相对50日均线+6.4%
- 相对200日均线+8.3%
- 52周区间低于52周高点13.3% · 高于52周低点154.2%
- 连续走势连续3个交易日上涨
- 均线交叉金叉（11个交易日前）
- 50日均线交叉股价向上穿越50日均线（13个交易日前）
- 随机指标%K 43.7 · %D 41.3（金叉）
FAQ · from the current data · as of 2026-09-21
Quick answers
BLTE当前的Closelook信号是什么？
Uptrend stack intact — Trades +6.4% vs the 50-day and +8.3% vs the 200-day average, 13.3% below the 52-week high and +154.2% off the 52-week low; a golden cross printed 11 sessions ago. Computed from daily closes.（截至2026-09-21；信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数，不构成投资建议。）
BLTE目前是否位于50日和200日均线上方？
截至2026-09-21，Belite Bio Inc ADR位于50日均线上方（+6.4%），200日均线上方（+8.3%）；距20日均线+2.8%。
BLTE距52周高点有多远？
截至2026-09-21，低于52周高点13.3%，高于52周低点154.2%。
Related in the Closelook universe
then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- ONC BeiGene, Ltd.industry
- REGN Regeneron Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- MRNA Moderna Incindustry
- TWST Twist Bioscience Corpindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- RXRX Recursion Pharmaceuticals Incindustry
- HALO Halozyme Therapeutics Incindustry
- SMMT Summit Therapeutics PLCindustry
- GMAB Genmab ASindustry
- CRSP Crispr Therapeutics AGindustry
- IBRX Immunitybio Incindustry
- SRPT Sarepta Therapeutics Incindustry
- TGTX TG Therapeutics Incindustry
- EXEL Exelixis Incindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- INCY Incyte Corporationindustry